1 Introduction to Research & Analysis Reports 1.1 Artificial Blood Substitute Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 China Artificial Blood Substitute Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 China Artificial Blood Substitute Overall Market Size 2.1 China Artificial Blood Substitute Market Size: 2021 VS 2027 2.2 China Artificial Blood Substitute Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Artificial Blood Substitute Players in China Market 3.2 Top China Artificial Blood Substitute Companies Ranked by Revenue 3.3 China Artificial Blood Substitute Revenue by Companies 3.4 Top 3 and Top 5 Artificial Blood Substitute Companies in China Market, by Revenue in 2020 3.5 Companies Artificial Blood Substitute Product Type 3.6 Tier 1, Tier 2 and Tier 3 Artificial Blood Substitute Players in China Market 3.6.1 List of Tier 1 Artificial Blood Substitute Companies in China 3.6.2 List of Tier 2 and Tier 3 Artificial Blood Substitute Companies in China 4 Sights by Type 4.1 Overview 4.1.1 By Type - China Artificial Blood Substitute Market Size Markets, 2021 & 2027 4.1.2 Perfluorocarbon-based Oxygen Carrier (PFBOC) 4.1.3 Hemoglobin-based Oxygen Carrier (HBOC) 4.2 By Type - China Artificial Blood Substitute Revenue & Forecasts 4.2.1 By Type - China Artificial Blood Substitute Revenue, 2016-2021 4.2.2 By Type - China Artificial Blood Substitute Revenue, 2022-2027 4.2.3 By Type - China Artificial Blood Substitute Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - China Artificial Blood Substitute Market Size, 2021 & 2027 5.1.2 Military 5.1.3 Civil 5.2 By Application - China Artificial Blood Substitute Revenue & Forecasts 5.2.1 By Application - China Artificial Blood Substitute Revenue, 2016-2021 5.2.2 By Application - China Artificial Blood Substitute Revenue, 2022-2027 5.2.3 By Application - China Artificial Blood Substitute Revenue Market Share, 2016-2027 6 Artificial Blood Substitute Companies Profiles 6.1 Aurum Biosciences Ltd. 6.1.1 Aurum Biosciences Ltd. Company Details 6.1.2 Aurum Biosciences Ltd. Business Overview 6.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Introduction 6.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue in China Market (2016-2021) 6.1.5 Aurum Biosciences Ltd. Recent Developments 6.2 HEMARINA SA 6.2.1 HEMARINA SA Company Details 6.2.2 HEMARINA SA Business Overview 6.2.3 HEMARINA SA Artificial Blood Substitute Introduction 6.2.4 HEMARINA SA Artificial Blood Substitute Revenue in China Market (2016-2021) 6.2.5 HEMARINA SA Recent Developments 6.3 HbO2 Therapeutics 6.3.1 HbO2 Therapeutics Company Details 6.3.2 HbO2 Therapeutics Business Overview 6.3.3 HbO2 Therapeutics Artificial Blood Substitute Introduction 6.3.4 HbO2 Therapeutics Artificial Blood Substitute Revenue in China Market (2016-2021) 6.3.5 HbO2 Therapeutics Recent Developments 6.4 KaloCyte Inc. 6.4.1 KaloCyte Inc. Company Details 6.4.2 KaloCyte Inc. Business Overview 6.4.3 KaloCyte Inc. Artificial Blood Substitute Introduction 6.4.4 KaloCyte Inc. Artificial Blood Substitute Revenue in China Market (2016-2021) 6.4.5 KaloCyte Inc. Recent Developments 6.5 SpheriTech Ltd. 6.5.1 SpheriTech Ltd. Company Details 6.5.2 SpheriTech Ltd. Business Overview 6.5.3 SpheriTech Ltd. Artificial Blood Substitute Introduction 6.5.4 SpheriTech Ltd. Artificial Blood Substitute Revenue in China Market (2016-2021) 6.5.5 SpheriTech Ltd. Recent Developments 6.6 NuvOx Pharma 6.6.1 NuvOx Pharma Company Details 6.6.2 NuvOx Pharma Business Overview 6.6.3 NuvOx Pharma Artificial Blood Substitute Introduction 6.6.4 NuvOx Pharma Artificial Blood Substitute Revenue in China Market (2016-2021) 6.6.5 NuvOx Pharma Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer

List of Tables Table 1. Artificial Blood Substitute Market Opportunities & Trends in China Market Table 2. Artificial Blood Substitute Market Drivers in China Market Table 3. Artificial Blood Substitute Market Restraints in China Market Table 4. Key Players of Artificial Blood Substitute in China Market Table 5. Top Artificial Blood Substitute Players in China Market, Ranking by Revenue (2019) Table 6. China Artificial Blood Substitute Revenue by Companies, (US$, Mn), 2016-2021 Table 7. China Artificial Blood Substitute Revenue Share by Companies, 2016-2021 Table 8. Companies Artificial Blood Substitute Product Type Table 9. List of Tier 1 Artificial Blood Substitute Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Artificial Blood Substitute Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type – China Artificial Blood Substitute Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - China Artificial Blood Substitute Revenue (US$, Mn), 2016-2021 Table 13. By Type - China Artificial Blood Substitute Revenue (US$, Mn), 2022-2027 Table 14. By Application – China Artificial Blood Substitute Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - China Artificial Blood Substitute Revenue (US$, Mn), 2016-2021 Table 16. By Application - China Artificial Blood Substitute Revenue (US$, Mn), 2022-2027 Table 17. Aurum Biosciences Ltd. Company Details Table 18. Aurum Biosciences Ltd. Business Overview Table 19. Aurum Biosciences Ltd. Artificial Blood Substitute Product Table 20. Aurum Biosciences Ltd. Artificial Blood Substitute Revenue in China Market (2016-2021) & (US$ Million) Table 21. Aurum Biosciences Ltd. Recent Developments Table 22. HEMARINA SA Company Details Table 23. HEMARINA SA Business Overview Table 24. HEMARINA SA Artificial Blood Substitute Product Table 25. HEMARINA SA Artificial Blood Substitute Revenue in China Market (2016-2021) & (US$ Million) Table 26. HEMARINA SA Recent Developments Table 27. HbO2 Therapeutics Company Details Table 28. HbO2 Therapeutics Business Overview Table 29. HbO2 Therapeutics Artificial Blood Substitute Product Table 30. HbO2 Therapeutics Artificial Blood Substitute Revenue in China Market (2016-2021) & (US$ Million) Table 31. HbO2 Therapeutics Recent Developments Table 32. KaloCyte Inc. Company Details Table 33. KaloCyte Inc. Business Overview Table 34. KaloCyte Inc. Artificial Blood Substitute Product Table 35. KaloCyte Inc. Artificial Blood Substitute Revenue in China Market (2016-2021) & (US$ Million) Table 36. KaloCyte Inc. Recent Developments Table 37. SpheriTech Ltd. Company Details Table 38. SpheriTech Ltd. Business Overview Table 39. SpheriTech Ltd. Artificial Blood Substitute Product Table 40. SpheriTech Ltd. Artificial Blood Substitute Revenue in China Market (2016-2021) & (US$ Million) Table 41. SpheriTech Ltd. Recent Developments Table 42. NuvOx Pharma Company Details Table 43. NuvOx Pharma Business Overview Table 44. NuvOx Pharma Artificial Blood Substitute Product Table 45. NuvOx Pharma Artificial Blood Substitute Revenue in China Market (2016-2021) & (US$ Million) Table 46. NuvOx Pharma Recent Developments List of Figures Figure 1. Artificial Blood Substitute Segment by Type Figure 2. Artificial Blood Substitute Segment by Application Figure 3. China Artificial Blood Substitute Market Overview: 2020 Figure 4. China Artificial Blood Substitute Market Size: 2021 VS 2027 (US$, Mn) Figure 5. China Artificial Blood Substitute Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Artificial Blood Substitute Revenue in 2020 Figure 7. By Type - China Artificial Blood Substitute Revenue Market Share, 2016-2027 Figure 8. By Application - China Artificial Blood Substitute Revenue Market Share, 2016-2027 Figure 9. Aurum Biosciences Ltd. Artificial Blood Substitute Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. HEMARINA SA Artificial Blood Substitute Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. HbO2 Therapeutics Artificial Blood Substitute Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. KaloCyte Inc. Artificial Blood Substitute Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. SpheriTech Ltd. Artificial Blood Substitute Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 14. NuvOx Pharma Artificial Blood Substitute Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Aurum Biosciences Ltd. HEMARINA SA HbO2 Therapeutics KaloCyte Inc. SpheriTech Ltd. NuvOx Pharma